Alembic Pharma Gets US FDA Approval for Valganciclovir
Alembic Pharmaceuticals has received US FDA final approval for Valganciclovir Oral Solution 50 mg/mL, a generic equivalent of Valcyte by CHEPLAPHARM.
Alembic Pharmaceuticals ANDA Approval | 28/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy